Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Apple Inc. (AAPL) Isn’t Cheap: Sony Corporation (ADR) (SNE), Google Inc (GOOG)

Page 1 of 2

Trading near 52-week lows, Apple Inc. (NASDAQ:AAPL) shares may appear “cheap” to many traders. However, the company is facing a major problem in 2013: the commoditization of its core business. Even at these levels, Apple shares could have significant downside in 2013.

The importance of the iPhone can’t be understated
At first glance, Apple Inc. (NASDAQ:AAPL) seems to be exposed to a number of different business: traditional laptops with its Macbook Pro, mp3 players with its iPod, tablets with the iPad and of course, smartphones with its iPhone.

Apple Inc. (NASDAQ:AAPL)

Yet, although it seems to be involved in a number of different product lines, the simple fact is that Apple is primarily a smartphone company. Business Insider noted back in August that roughly two-thirds of Apple’s profit comes from the iPhone — the device simply overwhelms the rest of the company.

Perhaps it’s then no coincidence that Apple’s stunning drop last fall coincided with a flurry of negative reports suggesting that iPhone demand was softer than anticipated over the holiday season.

Android has finally commoditized the smartphone business
About three months before Apple Inc. (NASDAQ:AAPL) shares hit their all-time high, Samsung released the Galaxy S3. In retrospect, it was a watershed moment, as for the first time, there was a phone on the market that was arguably better than (or at least as good as) the iPhone.

But the Galaxy S3 is just the beginning, it isn’t only Samsung that Apple has to worry about. This year will bring at least half a dozen smartphones to the market that will all challenge the iPhone for supremacy.

In addition to Samsung’s follow-up to the S3 (the S4), there will also be Sony Corporation (NYSE:SNE)’s Xperia Z — a 5-inch, supercharged, waterproof Android phone. Then there’s Motorola’s rumored “Xphone,” and new flagships from HTC and LG. There might even be new entrants to the market, like China’s Huawei.

All of these phones will have impressive processors, great cameras and HD screens. In short, 2013 is the year in which a business that Apple once enjoyed a monopoly in (the high-end smartphone market) will fully become a commodity business.

Basic economics dictates that commodity businesses aren’t capable of generating the type of profits that Apple has enjoyed for the last two years.

Sony Corporation (NYSE:SNE) faced the same issues
Apple has often been compared to Sony. In the 1980s and into the 1990s, Sony was riding high, living off its Walkman and Trinitron TV.

Then something happened. Sony Corporation (ADR) (NYSE:SNE) stopped innovating; its products slowly became commodities. The patent on the technology in the Trinitron, for example, expired in 1996, and Sony Corporation (ADR) (NYSE:SNE) immediately met a host of competitors.

If one ignores the tech bubble of the late ’90s (a time when nearly all tech stocks rallied to unreasonable levels), Sony’s stock has largely been range-bound over the last 20 years.

Apple’s CEO Tim Cook told Brian Williams last December that he believed Sony’s problems stemmed from a lack of focus. While it may be true that Sony’s business is stretched to an excessive degree, the company had a larger problem. In the 1980s, people specifically wanted Sony TVs, stereos and tape-players; by the late 1990s, they no longer cared.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!